Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Award Notice opportunity from Department Of Veterans Affairs was posted on February 4, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

6505--Metoprolol Tartrate IR Tablets Effective 5/8/2026 - 5/7/2027

Awarded
36E79725R0071Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The contract involves the procurement of Metoprolol Tartrate Tablets for the Department of Veterans Affairs, with the solicitation issued under number 36E79725R0071. The procurement aims to supply various dosages and packaging configurations of the medication, with a contract duration of one year and four additional one-year options. The solicitation, issued electronically, initially set the offer due date for November 18, 2025, but an amendment has extended this deadline to November 21, 2025, at 2:30 PM Central Time. The contract is targeted at responsible offerors capable of providing the specified drug in compliance with detailed requirements, including the inclusion of a 0.5% Cost Recovery Fee and unique National Drug Code (NDC) numbers for each drug offering. The procurement follows FAR Part 12 commercial item procedures and NAICS code 325412, with estimated annual usage quantities outlined for different strengths and package sizes. The point of contact for this solicitation is Contract Specialist Ray Roldan, based in Hines, Illinois. The overall goal is to establish a reliable supply chain for this essential medication across multiple federal healthcare agencies, ensuring continuity of care for veterans and other federal patients.

General Info

VA issues RFP for one-year Metoprolol supply with four one-year options, no relabeling allowed.

Contract Value

$0

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

IL, USA

Set-Aside

NONE

Award Issued Date

Documents

3
DOCX, High priority: read this firstamendment
High
DOCX, High priority: read this first71 pages · rfq
High
DOCX, Low priorityaward
Low

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

1 update
PhaseAwarded
Posted

Solicitation

Notice updated

Response deadline changed from Nov 18, 2025 to Nov 21, 2025. The notice description changed.

Awarded

Contract was awarded

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)
Contacts1 person available
OfficeHINES, IL, 60141, USA
Office AddressHINES, IL, 60141, USA
Contacts
Ray RoldanContract Specialist

Full Description

Show more
Metoprolol Tartrate IR Tablets

More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

Same awarding agency

NAICS: 325412
Federal
6505--Latanoprost Ophthalmic Solution (VA-27-00006027)
Solicitation # 36E79727R0039
The Department of Veterans Affairs is soliciting proposals for the procurement of Latanoprost 0.005% Ophthalmic Solution to ensure an uninterrupted supply for the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. This unrestricted commercial item procurement is structured into two groups, with one award made in the aggregate for either Group I (single bottles) or Group II (single and bulk cartons). The resulting contract will consist of a one-year base period followed by four pre-priced one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs, requiring the contractor to deliver supplies to designated distribution centers based on business-to-business agreements. Award will be granted based on the lowest evaluated price among proposals that meet all non-cost acceptability standards. Offerors must provide a unique 11-digit NDC number and adhere to the American Academy of Ophthalmology’s uniform color-coding system for caps and labels. Strict compliance with FDA current Good Manufacturing Practice standards is required, and offerors must certify they possess the necessary NDA, ANDA, or BLA approvals. Additionally, products must meet rigorous barcoding and serialization requirements under the Drug Supply Chain Security Act, including the use of GS-1 data matrix codes. Proposals must be submitted by November 17, 2026, and must include a 0.5% cost recovery fee embedded in the pricing.
Pharmaceutical Preparation Manufacturing

POSTED

9 days ago

DEADLINE

in 9 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS